SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Linda Kaplan who wrote (1459)1/1/1998 1:35:00 PM
From: Dauntless  Read Replies (3) | Respond to of 7041
 
Linda & thread -

Although this is the Zonagen thread, another company, TXB has recently come under under attack by our local Purveyor of Poop. TXB is another Texas based (re:hillbilly) biotech firm & I have the good fortune (literally & financially) to be familiar with both. TXB has one drug through clinical trials, with the NDA already filed with the FDA & already granted expedited review - a decision is expected in the 1st quarter. They have two or three other drugs in clinical trials and many more in their R&D pipeline. Like many start-up companies they have had their ups & downs and have had to scrounge for money a time or two. If any of you have ever run a start-up or have knowledges of the challenges, you know what I'm talking about. Anyway, enough of this - the real reason for this post was to let you know who is on the Board of Directors of this newly identified scam.

John M. Pietruski
Chairman of the Board,
Retired Chairman and Chief Executive Officer,
Sterling Drug Inc.

David B. McWilliams
President and Chief Executive Officer

Rita R. Colwell, Ph.D.
President, University of Maryland
Biotechnology Institute

Frank C. Carlucci
Chairman,The Carlyle Group

Robert J. Cruikshank
Retired Senior Partner, Deloitte Touche LL

James A. Thomson, Ph.D.
President and Chief Executive Officer,
RAND Corporation

James T. Willerson, M.D.
Professor and Chairman, Department of Internal Medicine
The University of Texas Medical School
============================================================

Oh, and before I forget, the Advisory Director to the Company is:

Denton A. Cooley, M.D.
Surgeon-in-Chief,
The Texas Heart Institute

Dr. Cooley is well known by the investment community to seek out fraudulent companies as he desperately needs some extra spending cash.

============================================================
P.S. - In a prior life, Carlucci was the U.S. Secretary of Defense - so we know he a charlatan.

P.P.S. - The company was founded from the technology transfer program of the Univ. of Texas Medical School. The founding scientist, Dr. WIllerson is identified on the board - here's a link to his bio:

uth.tmc.edu

I think we should all thank the Purveyor of Poop for alerting us to these despicable people and their dirty little scheme!!!